SI-BONE, Inc. (SIBN)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, SI-BONE, Inc. currently loses $7.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 9
in 60 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About SI-BONE, Inc.
SI-BONE, Inc. develops and markets implantable solutions for musculoskeletal conditions in the sacropelvic region. Listed on the NASDAQ as SIBN, the company operates in medical devices and generated $200.9 million of revenue in FY2025. Its business centers on minimally invasive implants used to treat sacroiliac joint disorders, pelvic trauma, and related spine conditions.
Today's Snapshot
The session opened with SIBN slightly higher at 18.45, in line with a flat sector.
Trading Volume
Below 10d avg (476.7K)
146.2K
vs S&P 500 Today
Outperforming Market
+0.56%
Updated: September 10, 2026 at 14:48 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$16.75 - $18.79Buy
- RSI (14)46.41Neutral
- Stochastic %K (14, 3, 3)15.57Buy
- MACD Level (12, 26)0.09Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.